Dr Rachel Climie is a clinical exercise physiologist and Heart Foundation postdoctoral research fellow specialising in vascular ageing. She completed her PhD at the Menzies Institute for Medical Research and 2 years postdoctoral research studying cardiovascular epidemiology and arterial mechanics at Paris Research Center Cardiovasculaire (PARCC), France, where she is an Honorary Fellow.
Rachel is interested in the ageing of the blood vessels (vascular ageing), the consequences of early vascular ageing (from early life and also in patients with diabetes or cancer) and how exercise can be used to prevent or delay this. She has expertise in non-invasive techniques to determine vascular ageing. Rachel is a chief investigator on the European Collaboration in Science and Technology (COST) Action grant ($1M) VascAgeNet and is the lead of Working Group 5 responsible for education and dissemination.
Email address: email@example.com
Dr Rosa-Maria Bruno (MD, PhD) is an Internal Medicine and Hypertension specialist, currently conducting research at the Paris Cardiovascular Research Center (PARCC-INSERM) in France. She has authored more than100 publications in peer-reviewed, Pubmed-indexed scientific journals, with a H-index of 26 and more than 1800 citations.
Rosa-Maria’s main field of research is the non-invasive evaluation of functional and structural vascular alterations in traditional and emerging cardiovascular risk factors, as well as sympathetic regulation of vascular function in hypertension. She is a member of the Executive Committee of the Artery Society and of the ESC Council of Hypertension. She is among the initiators of the European Collaboration in Science and Technology (COST) Action VascAgeNet and leader of Working Group 4 (Data and research studies – big data approaches).
Email address: firstname.lastname@example.org
Prof Elaine Urbina is a Professor of Paediatrics (Cardiology) and the Director of Preventive Cardiology at Cincinnati Children’s Hospital Medical Centre. She began her Paediatric residency at University of San Francisco and then completed her Paediatric Cardiology fellowship at Tulane University in New Orleans, LA. where she began her research career with the Bogalusa Heart Study (BHS) under the leadership of Dr. Gerald Berenson. She went on to join the staff of Tulane and led the non-invasive CV imaging studies for the BHS for over a decade.
Currently, Elaine’s clinical activities and industry sponsored grants focus on prevention (obesity, hypertension and dyslipidaemias) while her research grants (AHA, NIH) and Masters in Epidemiology training concentrate on new non-invasive methods of assessing atherosclerotic CV target organ damage in youth related to CV risk factors especially those that cluster with obesity. She continues to pursue her own research and also provides cardiac and vascular training and/or core services to a variety of multi-centre NIH-funded paediatric studies including CKiDs (chronic kidney disease), TODAY2 (type 2 diabetes), SEARCH 3 (type 1 diabetes), Udenefil & FUEL (single ventricle), and DoIT (dyslipidaemia). Elaine is a Fellow of the American Heart Association and immediate past chair of the Atherosclerosis, Hypertension and Obesity in Youth committee of the CV Disease in the Young council of AHA. She is also a member of the AHA research committee.
Email address: email@example.com
Prof Pierre Boutouyrie is clinical pharmacologist and cardiologist. He is involved in cardiovascular research from rare vascular diseases to large epidemiological cohorts. He has published more than 270 papers in international peer review journals, culminating in the Lancet (2010, 2016), European Heart Journal (2006, 2010, 2014), Circulation Research (2015). Prof. Pierre Boutouyrie has published more than 100 book chapters. He has an H-index of 67 with more than 20,000 citations, his 3 most cited papers cumulate more than 8,000 citations, which ranks them among the 0.001% top papers. He is involved in research networks at European and World level and has led multiple initiatives for establishing reference values for arterial parameters worldwide.
Pierre is the current president of the ARTERY society, former chair of the Working Group on large arteries from European Society of hypertension, member of the French society of Pharmacology and therapeutics, the French Societies of Cardiology and Hypertension.
Email address: firstname.lastname@example.org